Adult T-cell leukemia/lymphoma treatment in Bahia, Brazil
نویسندگان
چکیده
منابع مشابه
Adult T-cell leukemia/lymphoma treatment in Bahia, Brazil
BACKGROUND Adult T-cell leukemia/lymphoma is a peripheral disease associated with human T-cell lymphotropic virus type 1. Treatment is carried out according to clinical type with watchful waiting being recommended for less aggressive types. Aggressive adult T-cell leukemia/lymphoma is generally treated with chemotherapy and/or antivirals. The objective of this study was to correlate the surviva...
متن کاملSpecific cutaneous manifestations in adult T cell leukemia/lymphoma
Background and aim: Adult T cell leukemia/lymphoma (ATLL) is an aggresive malignancy which may occur in human T lymphotropic virus1(HTLV1) infected persons. HTLV1 is endemic in Khorasan with prevalence of 2.3% in general population. Since specific cutaneous manifestations of lymphoma may occur in a significant number of patients, we studied ATLL patients in Mashhad.Mate...
متن کاملEndomyocardial Fibrosis in Bahia, Brazil.
Endomyocardial fibrosis was originally reported as a prevalent condition leading to fatal cardiac failure in Uganda (Davies, 1960; Shillingford and Somers, 1961). Shortly afterwards, reports of new cases came from other African regions (Turner and Manson-Bahr, 1960; Abrahams, 1962) and isolated cases were recognized in America (Ishak and Tschumy, 1962), Europe (Lynch and Watt, 1957; Faruque, 19...
متن کاملAltered expression of cell cycle regulators in adult T-cell leukemia/lymphoma patients
Abstract Background: Adult T-cell leukemia/lymphoma (ATLL) is caused by human T-cell lymphotropic virus type-1 (HTLV-1). HTLV-1 oncogenes can induce malignancy through controlled gene expression of cell cycle checkpoints in the host cell. HTLV-I genes play a pivotal role in overriding cell cycle checkpoints and deregulate cellular division. In this study, we aimed to determine and comp...
متن کامل[Treatment of adult T-cell leukemia].
The treatment strategy for adult T-cell leukemia has not been established. CHOP derived combination chemotherapy protocols such as VEPA and VEPAM have failed to yield high complete remission rates and long survivals. Second or third generation combination chemotherapy regimens using alternative non-cross resistant drugs also have not achieved satisfactory results. A new multi-institutional tria...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista Brasileira de Hematologia e Hemoterapia
سال: 2017
ISSN: 1516-8484
DOI: 10.1016/j.bjhh.2016.09.012